Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an efflux system

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1817-1824

  Sutcliffe, Joyce ^a   Tait Kamradt, Amelia ^a   Wondrack, Lillian ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; CP 37277; ERYTHROMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; METHYLTRANSFERASE; MIKAMYCIN B; STREPTOGRAMIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG TRANSPORT; DRUG UPTAKE; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0029849428     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1817     Document Type: Article

References (77)

1. Andremont, A., G. Gerbaud, and P. Courvalin. 1986. Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob. Agents Chemother. 29:515-518.
2. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
3. Arthur, M., A. Andremont, and P. Courvalin. 1987. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob. Agents Chemother. 31:404-409.
4. Arthur, M., D. Autissier, and P. Courvalin. 1986. Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res. 14:4987-4999.
5. Arthur, M., C. Molinas, C. Mabilat, and P. Courvalin. 1990. Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob. Agents Chemother. 34:2024-2026.
6. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology, vol. 1, p. 2.4.1-2.4.4. John Wiley & Sons, New York.
7. Avery, O. T., C. M. MacLeod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J. Exp. Med. 79:137-158.
8. Azoulay-Dupuis, E., E. Vallee, B. Veber, and J. J. Pocidalo. 1992. Efficacy of RP 59500, a new-semi-synthetic streptogramin, against penicillin- and multi-resistant strains of Streptococcus pneumoniae (sp), p. 329, abstr. 1311. In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Barthélémy, P., D. Autissier, G. Gerbaud, and P. Courvalin. 1984. Enzymatic hydrolysis of erythromycin by a strain of Escherichia coli: a new mechanism of resistance. J. Antibiot. 37:1692-1696.
10. Bechhofer, D. H. 1990. Triple post-transcriptional control. Mol. Microbiol. 4:1419-1423.
11. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
12. Brisson-Noël, A., P. Delrieu, D. Samain, and P. Courvalin. 1988. Inactivation of lincosamide antibiotics in Staphylococcus. J. Biol. Chem. 263: 15880-15887.
13. Celmer, W. D., W. P. Cullen, C. E. Moppett, J. B. Routien, R. Shibakawa, and J. Tome. July 1977. U.S. patent 4,038,383.
14. α in a strain of Streptococcus pyogenes. Antimicrob. Agents Chemother. 5:534-537.
15. Coonan, K. M., and E. L. Kaplan. 1994. In vitro susceptibility of recent North American Group A streptococcal isolates to eleven oral antibiotics. Pediatr. Infect. Dis. J. 13:630-635.
16. Devriese, L. A. 1980. Two new types of resistance to lincomycin in pathogenic staphylococci from animals. Ann. Microbiol. (Paris) 131:261-266.
17. Djokic, S., G. Kobrehel, G. Lazarevski, N. Lopotar, Z. Tamburasev, G. Kamenar, A. Nagl, and I. Vickovic. 1986. Erythromycin series. Part II. Ring expansion of erythromycin A oxime by the Beckmann rearrangement. J. Chem. Soc. Perkin Trans. I 1986:1881-1890.
18. Dubnau, D. 1984. Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics. Crit. Rev. Biochem. 16:103-132.
19. Eady, E. A., J. I. Ross, J. L. Tipper, C. E. Walters, J. H. Cove, and W. C. Noble. 1993. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31:211-217.
20. Feigin, R. D., R. E. Keeney, J. Nusrala, P. G. Shackelford, and R. D. Lins. 1973. Efficacy of clindamycin therapy for otitis media. Arch. Otolaryngol. 98:27-31.
21. Fernandez-Munoz, R., R. E. Monro, R. Torres-Pinedo, and D. Vasquez. 1971. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur. J. Biochem. 23:185-193.
22. Fogel, S., and P. S. Sypherd. 1968. Extraction and isolation of individual ribosomal proteins from Escherichia coli. J. Bacteriol. 96:358-364.
23. Friedland, I. R., S. Shelton, M. Paris, et al. 1993. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 12:196-200.
24. Gerber, M. A. 1995. Antibiotic resistance in Group A streptococci. Pediatr. Clin. North Am. 42:539-551.
25. Girard, A. E., E. Girard, T. D. Goolz, J. A. Falella, and C. R. Cimochowski. 1995. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens. Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrob. Agents Chemother. 39:2210-2216.
26. Hagman, K. E., W. P. Pan, B. G. Spratt, J. T. Balthazar, R. C. Judd, and W. M. Shafer. 1995. Resistance of Neisseria gonorrhoeae to antimicrobial agents is modulated by the mtrRCDE efflux system. Microbiology 141:611-622.
27. Higgins, C. F., S. C. Hyde, M. M. Mimmack, U. Gileadi, D. R. Gill, and M. P. Gallagher. 1990. Binding protein-dependent transport systems. J. Bioenerg. Biomembr. 22:571-592.
28. Janosi, L., Y. Nakajima, and H. Hashimoto. 1990. Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus. Microbiol. Immunol. 34:723-735.
29. Klugman, K. P., and H. J. Koornhof. 1988. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J. Infect. Dis. 158:956-964.
30. Klugman, K. P., H. J. Koornhof, and V. Kuhnle. 1986. Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am. J. Dis. Child. 140:1186-1190.
31. Kono, M., K. O'Hara, and T. Ebisu. 1992. Purification and characterization of macrolide 2′-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics. FEMS Microbiol. Lett. 97:89-94.
32. Kreiswirth, B. M., S. Löfdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (London) 305:709-712.
33. Lai, C. J., and B. Weisblum. 1971. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 68:856-860.
34. Lampson, B. C., W. von David, and J. T. Parisi. 1986. Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidemidis. Antimicrob. Agents Chemother. 30:653-658.
35. Leclercq, R., A. Brisson-Noël, J. Duval, and P. Courvalin. 1987. Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp. Antimicrob. Agents Chemother. 31:1887-1891.
36. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
37. Leclercq, R., and P. Courvalin. 1991. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother. 35:1273-1276.
38. Leclercq, R., and P. Courvalin. 1993. Mechanisms of resistance to macrolides and functionally related antibiotics, p. 125-141. In A. J. Bryskier, J. P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides - chemistry, pharmacology, and clinical uses. Arnette, Blackwell, Paris.
39. Le Goffic, F., M. L. Capmau, J. Abbe, C. Cerceau, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PH1A, a pristinamycin 1A hydrolase. Ann. Inst. Pasteur (Paris) 128:471-474.
40. Le Goffic, F., M. L. Capmau, M. L. Bonnet, C. Cerceau, C. J. Soussy, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PACIIA, a new enzyme which modifies pristinamycin IIA. J. Antibiot. 30: 665-669.
41. Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem. Sci. 19:119-123.
42. Matsuoka, M., K. Endou, S. Saitoh, M. Katoh, and Y. Nakajima. 1995. A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary. Biol. Pharm. Bull. 18:1482-1486.
43. Matsuoka, M., L. Janosi. K. Endou, S. Saitoh, H. Hashimoto, and Y. Nakajima. 1993. An increase of 63kDa-protein present in the cell membranes of Staphylococcus aureus that bears a plasmid mediating inducible resistance to partial macrolide and streptogramin B antibiotics. Biol. Pharm. Bull. 16:1288-1290.
44. McCracken, G. H., Jr. 1995. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr. Infect. Dis. J. 14:424-428.
45. Meier, A., P. Kirschner, B. Springer, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Böttger. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
46. Milton, E. D., C. L. Hewitt, and C. R. Harwood. 1992. Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus. FEMS Microbiol. Lett. 97:141-147.
47. National Committee for Clinical Laboratory Standards. 1995. Suggested groupings of U.S. FDA-approved antimicrobial agents that should be considered for routine testing and reporting on fastidious organisms by clinical microbiology laboratories, table 1A. In J. H. Jorgensen, W. A. Craig, G. V. Doern, M. J. Ferraro, S. M. Finegold, J. Fung-Tomc, S. L. Hansen, J. Hindler, D. A Preston, L. B. Reller, J. M. Swenson, F. C. Tenover, M. A. Wikler, and W. R. Wilson (ed.), Performance standards for antimicrobial susceptibility testing, vol. 15, no. 14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
48. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
49. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
50. Nikaido, H., and D. G. Thanassi. 1993. Penetration of lipophilic agents with multiple proteonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
51. Noguchi, N., A. Emura, H. Matsuyama, K. O'Hara, M. Sasatsu, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2′-phosphotransferase 1 in Escherichia coli. Antimicrob. Agents Chemother. 39:2359-2363.
52. O'Hara, K. 1994. Application of nuclear magnetic resonance spectrometry to measure the activity of bacterial macrolide esterase. Microbios 79:231-239.
53. O'Hara, K., T. Kanda, K. Ohmiya, T. Ebisu, and M. Kono. 1989. Purification and characterization of macrolide 2′-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob. Agents Chemother. 33:1354-1357.
54. Ounissi, H., and P. Courvalin. 1985. Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli. Gene 35:271-278.
55. Pan, W., and B. G. Spratt. 1994. Regulation of the permeability of the gonococcal envelope by the mtr system. Mol. Microbiol. 11:769-775.
56. París, M. M., S. Shelton, M. Trujillo, S. M. Hickey, and G. H. McCracken, Jr. 1996. Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:122-126.
57. Pernodet, J. L., F. Boccard, M.-T. Alegre, M. H. Blondelet-Rouault, and M. Guérineau. 1988. Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. EMBO J. 7:277-282.
58. Phillips, G., D. Parratt, G. V. Orange, I. Harper, H. McEwan, and N. Young. 1990. Erythromycin-resistant Streptococcus pyogenes. J. Antimicrob. Chemother. 25:723-724.
59. Ross, J. I., E. A. Eady, J. H. Cove, and S. Baumberg. 1995. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 153:93-98.
60. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
61. Ross, J. I., A. M. Farrell, E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1989. Characterization and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J. Antimicrob. Chemother. 24:851-862.
62. Scott, R. J. D., J. Naidoo, N. F. Lighlfoot, and R. C. George. 1989. A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin. Epidemiol. Infect. 102:95-91.
63. Seppälä, H., A. Nissinen, H. Järvinen, S. Huovinen, T. Henriksson, E. Herva, S. E. Holm, M. Jahkola, M.-L. Katila, T. Klaukka, S. Kontiainen, O. Liimatainen, S. Oinonen, L. Passi-Metsomaa, and P. Huovinen. 1992. Resistance to erythromycin in Group A streptococci. N. Engl. J. Med. 326:292-297.
64. Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
65. Shandler, L., J. Gonzales, and G. D. Overturf. 1996. Recurrence of pneumococcal sepsis caused by an intermediately penicillin-resistant organism treated with loracarbef. Pediatr. Infect. Dis. J. 15:379-380.
66. Spika, J. S., R. R. Facklam, B. D. Plikaytis, and M. J. Oxtoby. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The pneumococcal surveillance working group. J. Infect. Dis. 163: 1273-1278.
67. Stingemore, N., G. R. J. Francis, M. Toohey, and D. B. McGechie. 1989. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med. J. Aust. 150:626-631.
68. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. Detection of erythromycin-resistant determinants using the polymerase chain reaction. Submitted for publication.
69. Swendsen, C. L., and W. Johnson. 1976. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction. Infect. Immun. 14:345-354.
70. Thornsberry, C., S. D. Brown, Y. C. Yee, S. K. Bouchillon, J. K. Marler, and T. Rich. 1993. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Effect on susceptibility to oral cephalosporins. Infections Med. 10:15-24.
71. Weisblum, B. 1985. Inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression - a review. J. Antimicrob. Chemother. 16(Suppl. A):63-90.
72. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.
73. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805.
74. Welby, P. E., D. S. Keller, J. L. Cromien, P. Tebas, and G. A. Storch. 1994. Resistance to penicillin and non-β-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr. Infect. Dis. J. 13:281-287.
75. Wondrack, L., M. Massa, B. V. Yang, and J. Sutcliffe. 1996. A clinical strain of Staphylococcus aureus inactivates and effluxes macrolides. Antimicrob. Agents Chemother. 40:992-998.
76. Wondrack, L., and J. Sutcliffe. 1995. Streptococcus strains with a M phenotype efflux erythromycin, a 14-membered macrolide, p. 158, abstr. A-85. In Abstracts of the 95th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
77. Youngs, E. R. 1984. Erythromycin resistant Streptococcus pyogenes in Merseyside. J. Infect. 8:86-87.